Sandbox:DN: Difference between revisions

Revision as of 15:40, 4 November 2016 (view source) Dima Nimri (talk \| contribs) No edit summary ← Older edit		Latest revision as of 16:11, 19 January 2017 (view source) Dima Nimri (talk \| contribs) (Blanked the page) Tag: Visual edit
(80 intermediate revisions by 2 users not shown)
Line 1:		Line 1:
	~~==Overview==~~

	Dual antiplatelet therapy (or DAPT) refers to the combination of [[aspirin]] and a P2Y12 receptor antagonist. DAPT is approved for [[SIHD]] and interventions for [[ACS]], such as stent placement following [[PCI]] or [[CABG]]. The duration of treatment with DAPT for each of these categories differs and guidelines for treatment have been updated in the ''2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease''. Much of the studies done on DAPT compared the use of different types of P2Y12 receptor antagonists, the dosage of drugs, as well as the duration of treatment. The current consensus is that the use of DAPT is associated with decreased risk of [[stent thrombosis]], [[MI]] and [[stroke]]. However, the benefits of treatment should be weighed against the increased risk of major bleeding in certain patient populations.

Latest revision as of 16:11, 19 January 2017